APA (7th ed.) Citation

J, F., KM, O., K, R., B, S., JC, K., DH, P., . . . KG, K. (2026). Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept. Pulmonary circulation, 16(2), e70324. https://doi.org/10.1002/pul2.70324

Chicago Style (17th ed.) Citation

J, Fuge, Olsson KM, Remmert K, Stapel B, Kamp JC, Park DH, Hoeper MM, Winter L, and Kahl KG. "Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept." Pulmonary Circulation 16, no. 2 (2026): e70324. https://doi.org/10.1002/pul2.70324.

MLA (9th ed.) Citation

J, Fuge, et al. "Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept." Pulmonary Circulation, vol. 16, no. 2, 2026, p. e70324, https://doi.org/10.1002/pul2.70324.